Clinical research

Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults

EuroIntervention 2010;6:604-610.

Justin G.L.M. Luermans, MD, PhD; Martijn C. Post*, MD, PhD; Jurriën M. ten Berg, MD, PhD; H.W. Thijs Plokker, MD, PhD; Maarten J. Suttorp, MD, PhD

Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands

Aims: Transcatheter closure of the secundum-type atrial septal defect (ASD) is widely practised. We report complications and efficacy of percutaneous ASD closure in adults using the Amplatz

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

atrial septal defecttranscatheter closure

Share on Facebook Share on Twitter Share on Linkedin

Latest news

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions

November 19, 2021

NEW ISSUE

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

NEWS

EuroIntervention is now on Instagram

November 29, 2021

AHEAD OF PRINT

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

EDITORIAL

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

EDITORIAL

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

CONSENSUS

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers